The effect of introduction by means of electroporation of protogene ras into cells of antibody-producing hybridoma was studied. Doubling time (TD) of transduced subclones, in which H-ras gene was expressed, proved to be 1.8-fold shorter as compared to the parent line. Other characteristics of the hybridoma (cloning efficiency, antibody production in vitro, the time of ascitic fluid appearance in mice and antibody titer in vivo) were not changed. Addition of 12-0-tetradecanoylphorbol acetate to the culture did not alter the growth parameters of H-ras transduced subclones.

Download full-text PDF

Source

Publication Analysis

Top Keywords

transduced subclones
8
[transduction oncogene
4
oncogene ras
4
ras antibody-producing
4
antibody-producing hybridoma]
4
hybridoma] introduction
4
introduction electroporation
4
electroporation protogene
4
protogene ras
4
ras cells
4

Similar Publications

Cas-CLOVER-mediated knockout of STAT1: A novel approach to engineer packaging HEK-293 cell lines used for rAAV production.

Biotechnol J

September 2024

Gene Therapy Process Development, Baxalta Innovations GmbH, a part of Takeda companies, Orth an der Donau, Austria.

In addressing the limitations of CRISPR-Cas9, including off-target effects and high licensing fees for commercial use, Cas-CLOVER, a dimeric gene editing tool activated by two guide RNAs, was recently developed. This study focused on implementing and evaluating Cas-CLOVER in HEK-293 cells used for recombinant adeno-associated virus (rAAV) production by targeting the signal transducer and activator of transcription 1 (STAT1) locus, which is crucial for cell growth regulation and might influence rAAV production yields. Cas-CLOVER demonstrated impressive efficiency in gene editing, achieving over 90% knockout (KO) success.

View Article and Find Full Text PDF

Overexpression of aspartic proteases, as cathepsin D, is an independent marker of poor prognosis in breast cancer, correlated with the incidence of clinical metastasis. We aimed to find if HIV-1 aspartic protease (PR) can play a similar role. Murine adenocarcinoma 4T1luc2 cells were transduced with lentivirus encoding inactivated drug-resistant PR, generating subclones PR20.

View Article and Find Full Text PDF

AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.

Proc Natl Acad Sci U S A

June 2024

Melanoma Research Team, Center for Autophagy, Recycling and Disease, Danish Cancer Institute, Copenhagen 2100, Denmark.

Article Synopsis
  • Resistance to MAPK inhibitors in melanoma is linked to lower levels of the tumor suppressor AMBRA1, which predicts poor treatment response.
  • Loss of AMBRA1 triggers phenotype changes and leads to a resistance mechanism that bypasses the usual pathways, increasing reliance on FAK1.
  • Combining MAPK inhibitors with FAK1 inhibitors can effectively prevent resistance in melanomas that have low AMBRA1 expression, highlighting AMBRA1's potential as a predictive marker for treatment efficacy.
View Article and Find Full Text PDF

Background: It has been discovered that Janus kinase 2 () exon12 mutations lead to the polycythemia vera (PV) phenotype, while somatic mutations of calreticulin () are associated with essential thrombocythemia (ET) or primary myelofibrosis. In this article, we report a case of ET with coexistence of exon12 and mutations. The objective of this study was to elucidate the pathogenicity mechanism of a exon12 mutation (N533S) and the role of the coexistence of mutations on the hematological phenotype.

View Article and Find Full Text PDF

Background: Epithelial-to-mesenchymal transition (EMT) plays a role in the invasion and metastasis of cancer cells. During this phenomenon, Snail can promote tumor progression by upregulating mesenchymal factors and downregulating the expression of pro-apoptotic proteins.

Objective: Therefore, interventions on the expression rate of Snails may show beneficial therapeutic applications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!